Back
Ardelyx 10K Form
Sell
32
ARDX
Ardelyx
Last Price:
$5.04
Seasonality Move:
-11.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARDX News And Ratings
See the #1 stock for the next 7 days that we like better than ARDX
ARDX Financial Statistics
Sales & Book Value
| Annual Sales: | $333.6M |
|---|---|
| Cash Flow: | $9.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.73 |
| Price / Book: | 7.14 |
Profitability
| EPS (TTM): | -0.16340 |
|---|---|
| Net Income (TTM): | $-39.1M |
| Gross Margin: | $283.1M |
| Return on Equity: | -24.57% |
| Return on Assets: | -10.95% |
Ardelyx Earnings Forecast
Key Ardelyx Financial Ratios
-
The Gross Profit Margin over the past 12 years for ARDX is 84.85%.
-
The Selling, General & Administrative Expenses for ARDX have been equal to 77.54% of Gross Profit Margin.
-
The Research & Development expenses have been 15.68% of Revenue.
-
The Net Earning history of ARDX is -11.73% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 8 years.
Ardelyx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARDX |
| CUSIP: | 039697 |
| Website: | ardelyx.com |
Debt
| Debt-to-Equity Ratio: | 0.87 |
|---|---|
| Current Ratio: | 4.58 |
| Quick Ratio: | 3.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 18.9 |